Financing, Equity Capital Markets

Rigel Pharmaceuticals, Inc.

04/18
|
$71.8 Million
Piper Sandler served as bookrunner for Rigel Pharmaceuticals, Inc. on a follow-on offering
Sub-Type
Follow-On Offering
Sub-Sector
Biopharma